These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 19803705

  • 1. Topical antibiotic treatment for uncomplicated skin and skin structure infections: review of the literature.
    Pangilinan R, Tice A, Tillotson G.
    Expert Rev Anti Infect Ther; 2009 Oct; 7(8):957-65. PubMed ID: 19803705
    [Abstract] [Full Text] [Related]

  • 2. Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus.
    Elliott DJ, Zaoutis TE, Troxel AB, Loh A, Keren R.
    Pediatrics; 2009 Jun; 123(6):e959-66. PubMed ID: 19470525
    [Abstract] [Full Text] [Related]

  • 3. The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
    Lawrence KR, Golik MV, Davidson L.
    Am J Ther; 2009 Jun; 16(4):333-8. PubMed ID: 19617720
    [Abstract] [Full Text] [Related]

  • 4. Trimethoprim-sulfamethoxazole or clindamycin for treatment of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
    Hyun DY, Mason EO, Forbes A, Kaplan SL.
    Pediatr Infect Dis J; 2009 Jan; 28(1):57-9. PubMed ID: 19057459
    [Abstract] [Full Text] [Related]

  • 5. Treatment options for skin and soft tissue infections caused by meticillin-resistant Staphylococcus aureus:oralvs.parenteral; home vs. hospital.
    Esposito S, Leone S, Petta E, Noviello S, Ianniello F.
    Int J Antimicrob Agents; 2009 Jul; 34 Suppl 1():S30-5. PubMed ID: 19560673
    [Abstract] [Full Text] [Related]

  • 6. Treatment of skin and soft tissue infections due to community-associated methicillin-resistant Staphylococcus aureus in Europe: the role of trimethoprim-sulfamethoxazole0010.
    De Angelis G, Cipriani M, Cauda R, Tacconelli E.
    Clin Infect Dis; 2011 Jun 15; 52(12):1471-2; author reply 1472. PubMed ID: 21628490
    [No Abstract] [Full Text] [Related]

  • 7. Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus.
    Stryjewski ME, Chambers HF.
    Clin Infect Dis; 2008 Jun 01; 46 Suppl 5():S368-77. PubMed ID: 18462092
    [Abstract] [Full Text] [Related]

  • 8. Antibiotic options for treating community-acquired MRSA.
    Powell JP, Wenzel RP.
    Expert Rev Anti Infect Ther; 2008 Jun 01; 6(3):299-307. PubMed ID: 18588495
    [Abstract] [Full Text] [Related]

  • 9. Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus.
    Pallin DJ, Egan DJ, Pelletier AJ, Espinola JA, Hooper DC, Camargo CA.
    Ann Emerg Med; 2008 Mar 01; 51(3):291-8. PubMed ID: 18222564
    [Abstract] [Full Text] [Related]

  • 10. Minocycline, often forgotten but preferred to trimethoprim-sulfamethoxazole or doxycycline for the treatment of community-acquired meticillin-resistant Staphylococcus aureus skin and soft-tissue infections.
    Cunha BA.
    Int J Antimicrob Agents; 2013 Dec 01; 42(6):497-9. PubMed ID: 24126085
    [Abstract] [Full Text] [Related]

  • 11. [Managing children skin and soft tissue infections].
    Moulin F, Quinet B, Raymond J, Gillet Y, Cohen R.
    Arch Pediatr; 2008 Oct 01; 15 Suppl 2():S62-7. PubMed ID: 19000857
    [Abstract] [Full Text] [Related]

  • 12. Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome.
    Ruhe JJ, Smith N, Bradsher RW, Menon A.
    Clin Infect Dis; 2007 Mar 15; 44(6):777-84. PubMed ID: 17304447
    [Abstract] [Full Text] [Related]

  • 13. Oral antibiotic treatment for methicillin-resistant Staphylococcus aureus skin and soft tissue infections: review of the literature.
    Khawcharoenporn T, Alan T.
    Hawaii Med J; 2006 Oct 15; 65(10):290-3. PubMed ID: 17194061
    [Abstract] [Full Text] [Related]

  • 14. The problem of complicated skin and skin structure infections: the need for new agents.
    Moellering RC.
    J Antimicrob Chemother; 2010 Nov 15; 65 Suppl 4():iv3-8. PubMed ID: 21115452
    [Abstract] [Full Text] [Related]

  • 15. Epidemiology and treatment of community-associated methicillin-resistant Staphylococcus aureus in children.
    Marcinak JF, Frank AL.
    Expert Rev Anti Infect Ther; 2006 Feb 15; 4(1):91-100. PubMed ID: 16441212
    [Abstract] [Full Text] [Related]

  • 16. Caution when reconsidering empiric antimicrobial therapy for methicillin-resistant Staphylococcus aureus skin and soft-tissue infections.
    da Silva LV, Zavascki AP, de Souza MV, Marcadenti A.
    Am J Surg; 2008 Oct 15; 196(4):618-9. PubMed ID: 18809069
    [No Abstract] [Full Text] [Related]

  • 17. Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus.
    Lee MC, Rios AM, Aten MF, Mejias A, Cavuoti D, McCracken GH, Hardy RD.
    Pediatr Infect Dis J; 2004 Feb 15; 23(2):123-7. PubMed ID: 14872177
    [Abstract] [Full Text] [Related]

  • 18. Emerging drugs for complicated skin and skin-structure infections.
    Mendoza N, Tyring SK.
    Expert Opin Emerg Drugs; 2010 Sep 15; 15(3):509-20. PubMed ID: 20557269
    [Abstract] [Full Text] [Related]

  • 19. Oral beta-lactams applied to uncomplicated infections of skin and skin structures.
    Jacobs MR, Jones RN, Giordano PA.
    Diagn Microbiol Infect Dis; 2007 Mar 15; 57(3 Suppl):55S-65S. PubMed ID: 17292581
    [Abstract] [Full Text] [Related]

  • 20. Current treatment options for community-acquired methicillin-resistant Staphylococcus aureus infection.
    Moellering RC.
    Clin Infect Dis; 2008 Apr 01; 46(7):1032-7. PubMed ID: 18444820
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.